期刊文献+

伴噬血细胞综合征的外周T细胞淋巴瘤临床特点及生存分析 被引量:6

原文传递
导出
摘要 T细胞淋巴瘤是异质性相当大的一类非霍奇金淋巴瘤(NHL),亚洲地区较其他地区多见,且以侵袭性T细胞淋巴瘤为主。我们随访了本院近5年来收治的113例初发外周T细胞淋巴瘤中合并嗜血细胞综合征的28例患者,并分析其临床特征,疗效和预后。
出处 《中华血液学杂志》 CAS CSCD 北大核心 2007年第10期698-699,共2页 Chinese Journal of Hematology
  • 引文网络
  • 相关文献

参考文献6

  • 1Janka GE, Schneider EM. Modem management of children with haemophagocytic lymphohistiocytosis. Br J Haematol, 2004, 124 : 4-14.
  • 2A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin' s lymphoma. The Non-Hodgkin' s Lymphoma Classification Project. Blood, 1997, 89 : 3909-3918.
  • 3Allory Y, Challine D, Haioun C, et al. Bone marrow involvement in lymphomas with hemophagocytic syndrome at presentation : a clinicopathologic study of 11 patients in a Western institution. Am J Surg Pathol, 2001,25: 865-874.
  • 4Tsuda H. Hemophagocytic syndrome (HPS) in children and adults. Int J Hematol, 1997, 65: 215-226.
  • 5Zidan J, Hussein O, Basher W, et al. Serum CA125 : a tumor marker for monitoring response to treatment and follow-up in patients with non-Hodgkin' s lymphoma. Oncologist, 2004, 9: 417-421.
  • 6Yanagiya N, Takahashi N, Nakae H, et al. Plasma exchange and continuous hemodiafiltration as an initial treatment for diffuse large B-cell lymphoma-associated hemophagocytic syndrome. Rinsho Ketsueki, 2002, 43 : 35-40.

同被引文献58

  • 1陈捷,吴颖,田红.淋巴瘤相关性嗜血细胞综合征28例临床诊治分析[J].实用医学杂志,2007,23(17):2714-2716. 被引量:8
  • 2CHAN J K C,QUINTANILLA-MARTINEZ L,FER-RY J A,et al. Extranodal NK/T-cell lymphoma,nasaltype[M]//SWERDLOW S,CAMPO E,HARRIS N,et al. WHO classification of tumours of haematolpoiet-ic and lymphoid tisvsues. Lyon: WHO press, 2008: 285-288.
  • 3HENTER J I,HORNE A, ARICO M, et al. HLH-2004 : Diagnostic and therapeutic guidelines for he-mophagocytic lymphohistiocytosis [ J ]. Pediatr BloodCancer,2007,48:124 —131.
  • 4IMASHUKU S. Treatment of Epstein-Barr virus-re-lated hemophagocytic lymphohistiocytosis ( EBV-HLH) ; update 2010 [J]. J Pediatr Hematol Oncol,2011,33:35-39.
  • 5SHIRAISHI A, OHGA S,DOI T, et al. Treatmentchoice of immunotherapy or further chemotherapy forEpstein-Barr virus-associated hemophagocytic lym-phohistiocytosis[J]. Pediatr Blood Cancer,2012,59 :265-270.
  • 6BELYEA B, HINSON A, MORAN C, et al. Spontane-ous resolution of Epstein-Barr virus-associated he-mophagocytic lymphohistiocytosis [ J], Pediatr BloodCancer,2010,55 : 754 — 756.
  • 7YAMAGUCHI M, TOBIN Al K,OGUCHI M,et al.Phase I/II study of concurrent chemoradiotherapy forlocalized nasal natural killer/T-cell lymphoma: JapanClinical Oncology Group Study JCOG0211 [J]. J ClinOncol,2009,27 : 5594_ 6600.
  • 8LIANG R. Advances in the management and monito-ring of extranodal NK/T-cell lymphoma, nasal type[J]. Br J Haematol .2009 ,147 : 13~ 21.
  • 9SUZUKI R,SUZUMIYA J, YAMAGUCHI M,et al.Prognostic factors for mature natural kille. (NK) cellneoplasms : aggressive NK cell leukemia and extranod-al NK cell lymphoma, nasal type [J]. Anne Oncol,2010,21:1032—1040.
  • 10HAN A R,LEE H R,PARK B B,et al. Lymphoma-associated hemophagocytic syndrome: clinical featuresand treatment outcome [J]. Ann Hematol,2007,86 :493-498.

引证文献6

二级引证文献19

;
使用帮助 返回顶部